Skip to content

Assessment of improvement in surgical quality in patients undergoing surgery for cervical spondylosis by giving a drug (dexmedetomidine) during the surgical procedure.

EFFECT OF DEXMEDETOMIDINE ON POSTOPERATIVE RECOVERY IN PATIENTS UNDERGOING CERVICAL SPINE SURGERY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/05/005759
Enrollment
64
Registered
2015-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PATIENTS SUFFERING FROM CERVICAL SPINE SPONDYLOSIS OR PROLAPSED INTERVERTEBRAL DISC AT CERVICAL SPINE LEVEL, AND UNDERGOING ANTERIOR CERVICAL DISCECTOMY AND FUSION SURGERY (ACDF)

Interventions

Intervention1: DEXMEDETOMIDINE INFUSION: IV infusion of dexmedetomidine (1µ/kg bolus over 10 min followed by 0.2 µg/kg/h as maintenance) started before induction of anaesthesia and continued till co

Sponsors

ALL INDIA INSTITUTE OF MEDICAL SCIENCES NEW DELHI
Lead Sponsor
DR ARVIND CHATURVEDI
Collaborator
DR MIHIR PRAKASH PANDIA
Collaborator
PROF PARMOD KUMAR BITHAL
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 64 adults of both sexes with the American Society of Anaesthesiologists (ASA) physical status I or II, aged 18 to 60 years, undergoing elective anterior cervical spine surgery for cervical spondylosis or prolapsed intervertebral disc were enrolled

Exclusion criteria

Exclusion criteria: Exclusion criteria included active smokers (history of smoking any time in past 6 months); preexisting bradycardia (HR below 50/min) or hypotension (systolic arterial pressure less than 100 mm Hg); planned elective ventilation post-operatively; poor respiratory reserve and poor cough reflex; presence of cardiac, renal, hepatic, and respiratory dysfunction; cognitive impairment; pregnancy or breast feeding; known allergy to alpha 2-agonists; and use of beta-blockers, cimetidine, digoxin, alpha 2-agonists or psychotropic medications.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure of this study was to assess post-operative recovery profile based on time to emergence.Timepoint: Emergence time was defined as time interval between discontinuing of anaesthetic agent and eye opening of patient either spontaneously or on verbal commands.

Secondary

MeasureTime frame
Secondary outcome measures included severity of coughing on emergence, time to attain Modified Aldrete Score (MAS) more than or equal to 9, total intraoperative sevoflurane/ fentanyl consumption, postoperative pain, time to first analgesic requirement in the postoperative period, perioperative haemodynamics, and incidence of postoperative complications including nausea, vomiting, shivering, and respiratory depression.Timepoint: at extubation, at ICU admission, till patient needed first analgesic dose in ICU

Countries

India

Contacts

Public ContactDR VARUN JAIN

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI

c.arvind61@yahoo.in9868398210

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026